Immunoregulation and antidepressant effect of ketamine

Major depressive disorder (MDD) is a common mental health disorder that brings severe disease burden worldwide. Traditional antidepressants are mainly targeted at monoamine neurotransmitters, with low remission rates and high recurrence rates. Ketamine is a noncompetitive glutamate N-methyl-d-aspart...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nan, Yao, Lihua, Wang, Peilin, Liu, Zhongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155793/
https://www.ncbi.nlm.nih.gov/pubmed/34079622
http://dx.doi.org/10.1515/tnsci-2020-0167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155793/
https://www.ncbi.nlm.nih.gov/pubmed/34079622
http://dx.doi.org/10.1515/tnsci-2020-0167

Ejemplares similares